New voter surge in early voting could sway battleground states in 2024 US presidential election    Civil Defense urges caution amid forecast of heavy rain to hit most Saudi regions until Monday    What's in it for FinTech startups in events like Biban24    Al Nassr and Al Hilal share points in intense Riyadh Derby draw    ImpaQ: Riyadh to host first Impact Makers Forum in December    Saudi Arabia ranks 12th globally in international visitor spending in 2023    SFDA chief discusses investment opportunities in food and pharmaceutical sectors with Chinese companies    Riyadh's Sports Boulevard receives Platinum ActiveScore certifications    Saudi Arabia refutes claims of rising worker fatalities, highlighting low work-related death rates    US says around 8,000 troops from North Korea are stationed in Russia's Kursk region    Spain mourns as death toll passes 150 in catastrophic floods    Seven killed in Israel in deadliest Hezbollah rocket strikes in months    Cyclists on phones face jail under Japan's new traffic laws    Hidden sugars in Asia's baby food spark concerns    Saleh Al Shehri strike seals Al Ittihad's Sea Derby win over Al Ahli    HONOR unveils pre-order of the stunning HONOR MagicBook Art 14 Featuring an ultra-slim design, HONOR Eye Comfort Display and AI Cross-OS WorkStation    Derby Week makes its debut in the Roshn Saudi League    Al Nassr eliminated from King's Cup after a defeat to Al Taawoun    Teri Garr, Young Frankenstein and Tootsie star, dies at 79    Indonesia Days event celebrates cultural diversity at Al Suwaidi Park    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Filipino pilgrim's incredible evolution from an enemy of Islam to its staunch advocate    Muted Eid celebrations for millions of Nigerian Muslims    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Rise in detection rate of genetic variants in individuals with ASD
Published in The Saudi Gazette on 21 - 01 - 2013

SALT LAKE CITY – Lineagen, Inc. today announced publication of the results of a 9,000-person genetic study that demonstrates an approximately 100 percent increase in the detection rate of genetic markers now validated as being associated with autism spectrum disorders (ASD).
The study, one of the largest genetic validation studies in autism, was designed to confirm novel copy number genetic variants and novel next-generation sequence variants associated with ASDs.
Researchers affiliated with The Children's Hospital of Philadelphia (CHOP), the University of Utah (Utah), Golden Helix, Inc, and Lineagen have confirmed in family and broad population studies a two-fold increase in the number of cases of ASD that can be ascribed to these newly identified genetic variants, specifically gene deletions or duplications (termed copy number variants, or CNVs).
To date, a validated genetic variant can be detected in about 5 to 7 percent of individuals with an ASD receiving current clinical genetic tests; with these findings, the percentage approaches 12 percent.
In addition, the study identified and confirms the involvement of biological pathways and reports the discovery of new gene regions that have relevance to neural, cardiovascular, and immune functions, for which targeted treatments are being developed in independent clinical trials.
This work allows for the increased detection of such variants so that companion diagnostics and targeted interventions leading to appropriate, personalized treatments for patients can be developed.
Further research on the pathways and regions is ongoing. Results from the studyhave beenpublishedin the current issue of PLOS ONE; a copy of the article can be accessed at http://dx.plos.org/10.1371/journal.pone.0052239.
Lineagen has incorporated these novel validated genetic variants into the next generation of its FirstStepDx genetic test, FirstStepDx PLUS.
FirstStepDx PLUS combines highly advanced genetic testing with fully integrated genetic counseling to accelerate and enhance the diagnostic evaluation of individuals with ASDs, developmental delay (DD), and intellectual disability (ID), and help physicians better direct clinical management for these individuals.
Mark F. Leppert , Ph.D., lead researcher and distinguished professor at the University of Utah's Department of Human Genetics, said: “Utah has long been leading the way in disease-relevant genetic discoveries.
“The newly identified variants were discovered based on gene sequences originally found in 38 multi-generational Utah families. The ability to replicate in the general population is a major step forward in understanding the genetic markers associated with ASD.”
Hakon Hakonarson , MD, PhD, lead researcher on the study and Director of CHOP's Center for Applied Genomics, commented: “This is one of the most comprehensive genetic studies of autism performed to date.
“The genetic variants confirmed by the study's large sample size give us confidence that they accurately represent the underlying biology of ASD.”
To evaluate the significance of the biological findings for this study, Lineagen utilized a unique approach that combined the talents of the highly respected research teams at Golden Helix and the CHOP Center for Applied Genomics.
CHOP and Golden Helix independently analyzed the study data using orthogonal techniques to identify statistically relevant results. Golden Helix CEO Christophe Lambert , PhD, said: “The methodology Lineagen implemented to discover novel genetic variants for ASDs demonstrates their commitment to providing an accurate and thorough genetic diagnostic test not currently available in the marketplace.”
Golden Helix is a leading bioinformatics organization, specializing in sequence and array-based SNP and copy number analysis, genetic association software, and analytic services.
Michael S. Paul , PhD, Lineagen's Chief Executive Officer, said: “At Lineagen, we believe that understanding a person's underlying genetics is a crucial component of the evaluation and clinical management of individuals with autism and other disorders of childhood development.
“With this in mind, we set out to combine Utah's unique genetic resources with world-class researchers at Utah, CHOP, and Golden Helix to further identify and validate genetic markers associated with ASDs. With these new findings, our next-generation high-density array, FirstStepDx PLUS, offers the most clinically actionable information per test result. By incorporating the variants into our new test, we will be able to provide clinicians with information that may affect the way patients with ASDs are evaluated and managed clinically.”
Lineagen's FirstStepDx PLUS and related autism-risk screening services have been developed with the specific intention of helping physicians, patients, and families navigate the diagnostic evaluation “odyssey” of individuals with autism spectrum disorders (ASDs) and other disorders of childhood development more efficiently.
FirstStepDx PLUS includes genetic counseling, the most advanced, customized chromosomal microarray analysis (CMA) clinically available, and a detailed, personalized report created specifically for each individual's case.
FirstStepDx PLUS is specifically designed to help parents, physicians, and other healthcare providers significantly shorten the time to clinical action, allowing access to proven clinical management and treatment approaches as early as possible.
The customized and proprietary CMA platform incorporated into FirstStepDx PLUS was developed in collaboration with Affymetrix under the Powered by Affymetrix program.
The FirstStepDx PLUS genetic test is available as a fast and painless cheek swab (FirstStepDx PLUS Buccal), eliminating the need for a blood draw. For more information about FirstStepDx PLUS, please call Lineagen at 888-888-OPEN (888-888-6736) or visit www.firststepdxplus.com. – SG


Clic here to read the story from its source.